Squarepoint Ops LLC Gilead Sciences, Inc. Put Options Transaction History

Squarepoint Ops LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $2.58 Million - $3.25 Million	38,700 Added 28.88%	172,700 $14.5 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $2.77 Million - $3.2 Million	43,900 Added 48.72%	134,000 $9.19 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $4.03 Million - $4.91 Million	56,300 Added 166.57%	90,100 $6.6 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $644,776 - $731,192	8,800 Added 35.2%	33,800 $2.74 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $1.5 Million - $1.72 Million	-19,800 Reduced 44.2%	25,000 $1.93 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2.67 Million - $3.05 Million	34,600 Added 339.22%	44,800 $3.72 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $49,856 - $71,576	800 Added 8.51%	10,200 $875,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $3.68 Million - $4.15 Million	-63,800 Reduced 87.16%	9,400 $581,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $20.9 Million - $26.2 Million	-360,400 Reduced 83.12%	73,200 $4.35 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $862,903 - $979,412	13,300 Added 3.16%	433,600 $31.5 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $7.2 Million - $7.77 Million	106,400 Added 33.9%	420,300 $29.4 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $13.8 Million - $15.1 Million	-218,000 Reduced 40.99%	313,900 $21.6 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $31.9 Million - $36.4 Million	531,900 New	531,900 $34.4 Million

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.